Djibouti vs Madagascar: Antiretroviral therapy coverage for PMTCT
Djibouti
38.0%
in 2024
Madagascar
30.0%
in 2024
Djibouti rank
74th
Madagascar rank
77th
Antiretroviral therapy coverage for PMTCT over time
- Djibouti
- Madagascar
How they compare
Djibouti currently reports 38.0% against 30.0% in Madagascar, a difference of 8.0%.
That makes Djibouti's figure about 1.3 times Madagascar's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Madagascar ahead.
Djibouti ranks 74th and Madagascar ranks 77th of 84 countries.
Djibouti has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Djibouti | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 6.4% | 1.1% | 5.3% | Djibouti |
| 2010s | 28.2% | 7.8% | 20.4% | Djibouti |
| 2020s | 34.0% | 21.4% | 12.6% | Djibouti |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Djibouti or Madagascar?
- Djibouti, at 38.0% against 30.0% in Madagascar as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Djibouti and Madagascar?
- 8.0%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and Madagascar?
- 25 years are reported by both, from 2000 to 2024.
- How do Djibouti and Madagascar rank globally for antiretroviral therapy coverage for pmtct?
- Djibouti ranks 74th and Madagascar ranks 77th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).